Patent Assignment
Reel/Frame 069612/0441
Assignment of Assignor's Interest
Recorded: 2024-12-17
Pages: 13
Assignors
SMITH, JESSE JEROME
Executed: 2021-02-24
KENNEDY, JODI MICHELLE
Executed: 2021-02-24
FARELLI, JEREMIAH D.
Executed: 2021-02-24
GOSS, KENDRICK ALAN
Executed: 2021-02-24
SCHEIDEGGER, ADAM WALTER
Executed: 2021-03-08
RAO, TIMSI
Executed: 2021-03-08
COBAUGH, CHRISTIAN WESSEL
Executed: 2021-02-24
KASSA, YOSEPH
Executed: 2021-03-08
Assignee
OMEGA THERAPEUTICS, INC.
140 FIRST STREET, SUITE 501, CAMBRIDGE, MASSACHUSETTS, 02141
Covered Property
(1)
COMPOSITIONS AND METHODS FOR MODULATING HEPATOCYTE NUCLEAR FACTOR 4-ALPHA (HNF4alpha) GENE EXPRESSION
Application:
18/637,630 →
Publication:
US 2024/0344061
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Interest
Feb 10, 2025
From: OMEGA THERAPEUTICS, INC.
To: PIONEERING MEDICINES 08- B, INC.
Reel/Frame 070167/0243 →
Assignment of Assignor's Interest
Feb 23, 2026
From: OMGA LIQUIDATING, INC. (F/K/A OMEGA THERAPEUTICS, INC.)
To: FLAGSHIP LABS 114, INC.
Reel/Frame 073860/0886 →
Change of Name
Apr 13, 2026
From: OMEGA THERAPEUTICS, INC.
To: OMGA LIQUIDATING, INC.
Reel/Frame 075384/0788 →
Change of Name
Apr 13, 2026
From: FLAGSHIP LABS 114, INC.
To: SEPIA THERAPEUTICS, INC.
Reel/Frame 075384/0845 →